NYSE:AFL

Aflac Incorporated (NYSE: AFL) Navigates Q2 2026 with Solid Earnings and Strategic Growth

Font: Financial Modeling Prep  • Aug 06, 2026

Market Chart
  • Aflac Incorporated (NYSE: AFL) reported Q2 2026 earnings per share (EPS) of $1.75, slightly below analyst estimates, while revenue reached $4.12 billion, narrowly exceeding projections.
  • Improved profitability in Japan, driven by an enhanced benefit-to-premium ratio forecast at 61.7%, was a key factor in Aflac's "solid earnings."
  • Aflac maintains strong financial stability, evidenced by 43 consecutive years of dividend increases and a healthy debt-to-equity ratio of 0.26, reflecting its commitment to long-term shareholder value.

Aflac is a major insurance company known for its supplemental health and life insurance products. The company operates significantly in both the United States and Japan, key markets for its financial services. In Japan, it offers specialized products like Anshin Palette and Miraito, while in the U.S., it focuses on providing essential supplemental health products for employers and their employees.

On August 6, 2026, Aflac reported its second-quarter financial results. The company announced an earnings per share (EPS) of $1.75. EPS represents the company's profit allocated to each outstanding share of common stock. This result was slightly below the analyst consensus estimate of $1.76 and the $1.77 projected by Zacks Investment Research.

For the same quarter, Aflac's revenue reached $4.12 billion, which narrowly surpassed the estimated $4.11 billion. However, this figure was below the $4.19 billion to $4.20 billion projected by some analysts. The company's Chairman and CEO, Daniel P. Amos, described the financial performance as "solid earnings" driven by the execution of their business strategy.

Analysts noted that improved profitability in Japan was a key factor. As highlighted by Zacks Equity Research, the benefit-to-premium ratio in Japan is forecast to improve to 61.7%. This crucial financial ratio measures the relationship between the cost of claims and the premiums earned. A lower ratio suggests better profitability, which helps offset lower premium income.

Aflac continues to focus on long-term shareholder value through strategic capital deployment and consistent dividends. The company boasts an impressive history of 43 consecutive years of dividend increases, a testament to its commitment to investors. Its robust financial stability is also reflected in its low debt-to-equity ratio of 0.26, which indicates that the company primarily uses equity rather than debt to finance its assets, highlighting a conservative investment strategy.

Market Overview
ENSC
Ensysce Biosciences, Inc.
$0.52
44.83%
SURG
SurgePays, Inc.
$0.33
45.48%
CELZ
Creative Medical Technology Holdings, Inc.
$1.15
71.95%
SPCX
Space Exploration Technologies Corp.
$114.92
6.14%
GAUZ
Gauzy Ltd. Ordinary Shares
$0.43
69.53%
ONFO
Onfolio Holdings, Inc.
$0.06
-17.36%
HTZ
Hertz Global Holdings, Inc.
$2.02
29.49%
NVDA
NVIDIA Corporation
$218.99
-0.10%
UWMC
UWM Holdings Corporation
$1.20
-34.78%
SOUN
SoundHound AI, Inc.
$7.08
10.11%